Skip to content

Frontlight ResearchEarly access

Trial site

Bausch Health Site 1712

Mainz, 55122, GermanyNot linked to an institution yet

1closed trial

The trials here

What the trial at this site is about, from its registry record.

Conditions: Ulcerative colitis

Closed trials

Completed
Study Evaluating Efficacy and Safety of Amiselimod (MT-1303) in Mild to Moderate Ulcerative Colitis
NCT04857112· Phase 2· Bausch Health Americas, Inc.· Source

Site data: ClinicalTrials.govUpdated 12 Nov 2026

Report an error

Bausch Health Site 1712: trial site – Frontlight Research